National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Meetings, 47971-47972 [2020-17233]
Download as PDF
<![CDATA[
47971
Federal Register / Vol. 85, No. 153 / Friday, August 7, 2020 / Notices
emailed or written, should be identified
by the title of the information collection.
SUPPLEMENTARY INFORMATION:
Description: The proposed study
would conduct web surveys with state
child welfare agency adoption program
managers. The study will also include
stakeholder telephone interviews with
selected child welfare agency
representatives. The web surveys and
stakeholder interviews are designed to
collect information about the types of
routine contact between agencies and
families after adoption or guardianship,
as well as agency procedures to track
child instability experiences after
adoption or guardianship.
Respondents: Child welfare agency
staff.
ANNUAL BURDEN ESTIMATES
Total/annual
number of
respondents
Instrument
Agency Web Survey—Adoption ......................................................................
Agency Web Survey—Guardianship ...............................................................
Stakeholder Interview Discussion Guide: Adoption .........................................
Stakeholder Interview Discussion Guide: Guardianship .................................
Estimated Total Annual Burden
Hours: 70.6.
Comments: The Department
specifically requests comments on (a)
whether the proposed collection of
information is necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) the quality, utility,
and clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Consideration will be given
to comments and suggestions submitted
within 60 days of this publication.
Authority: Child Abuse Prevention and
Treatment and Adoption Reform Act of 1978.
John M. Sweet Jr.,
ACF/OPRE Certifying Officer.
[FR Doc. 2020–17270 Filed 8–6–20; 8:45 am]
BILLING CODE 4184–25–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
jbell on DSKJLSW7X2PROD with NOTICES
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of
meetings of the National Diabetes and
Digestive and Kidney Diseases Advisory
Council.
The meetings will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
VerDate Sep<11>2014
20:25 Aug 06, 2020
Jkt 250001
50
20
30
12
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meetings will be closed to the
public in accordance with the
provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended.
The grant applications and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Diabetes and
Digestive and Kidney Diseases Advisory
Council.
Date: September 9, 2020.
Open: 10:30 a.m. to 1:30 p.m.
Agenda: To Present the Director’s Report
and other Scientific Presentations.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Virtual
Meeting).
Closed: 4:15 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Karl F. Malik, Ph.D.,
Director, Division of Extramural Activities,
National Institutes of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy
Boulevard, Room 7329, MSC 5452, Bethesda,
MD 20892, (301) 594–4757, malikk@
niddk.nih.gov.
Name of Committee: National Diabetes and
Digestive and Kidney Diseases Advisory
Council; Digestive Diseases and Nutrition.
Date: September 9, 2020.
Open: 2:00 p.m. to 3:00 p.m.
Agenda: To review the Division’s scientific
and planning activities.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
PO 00000
Frm 00028
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
1
1
1
1
Average
burden
hours per
response
.33
.25
1.17
1.17
Annual
burden
hours
16.5
5.0
35.1
14.0
Boulevard, Bethesda, MD 20892 (Virtual
Meeting).
Closed: 3:15 p.m. to 4:15 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Karl F. Malik, Ph.D.,
Director, Division of Extramural Activities,
National Institutes of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy
Boulevard, Room 7329, MSC 5452, Bethesda,
MD 20892, (301) 594–4757, malikk@
niddk.nih.gov.
Name of Committee: National Diabetes and
Digestive and Kidney Diseases Advisory
Council; Diabetes, Endocrinology, and
Metabolic Diseases Subcommittee.
Date: September 9, 2020.
Open: 2:00 p.m. to 3:00 p.m.
Agenda: To review the Division’s scientific
and planning activities.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Virtual
Meeting).
Closed: 3:15 p.m. to 4:15 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Karl F. Malik, Ph.D.,
Director, Division of Extramural Activities,
National Institutes of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy
Boulevard, Room 7329, MSC 5452, Bethesda,
MD 20892, (301) 594–4757, malikk@
niddk.nih.gov.
Name of Committee: National Diabetes and
Digestive and Kidney Diseases Advisory
Council; Kidney, Urologic, and Hematologic
Diseases.
Date: September 9, 2020.
Open: 2:00 p.m. to 3:00 p.m.
Agenda: To review the Division’s scientific
and planning activities.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Virtual
Meeting).
E:\FR\FM\07AUN1.SGM
07AUN1
47972
Federal Register / Vol. 85, No. 153 / Friday, August 7, 2020 / Notices
Closed: 3:15 p.m. to 4:15 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Karl F. Malik, Ph.D.,
Director, Division of Extramural Activities,
National Institutes of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy
Boulevard, Room 7329, MSC 5452, Bethesda,
MD 20892, (301) 594–4757, malikk@
niddk.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page:
www.niddk.nih.gov/fund/divisions/DEA/
Council/coundesc.html, where an agenda and
any additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: August 3, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–17233 Filed 8–6–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
jbell on DSKJLSW7X2PROD with NOTICES
Center for Scientific Review; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Fellowship:
Lung Diseases.
Date: August 19, 2020.
Time: 12:00 p.m. to 4:00 p.m.
VerDate Sep<11>2014
20:25 Aug 06, 2020
Jkt 250001
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Kimm Hamann, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4118A,
MSC 7814, Bethesda, MD 20892, (301) 435–
5575, hamannkj@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: August 4, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–17329 Filed 8–6–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Cognition and
Aging.
Date: September 22, 2020.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Bethesda, MD 20892 (Video Meeting).
Contact Person: Alexander Parsadanian,
Ph.D., Scientific Review Officer, Scientific
Review Branch, National Institute on Aging,
National Institutes of Health, Gateway
Building 2C/212, 7201 Wisconsin Avenue,
Bethesda, MD 20892, (301) 496–9666,
parsadaniana@nia.nih.gov.
PO 00000
Frm 00029
Fmt 4703
Sfmt 4703
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: August 3, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–17235 Filed 8–6–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Advisory
General Medical Sciences Council.
The meeting will be open to the
public as indicated below, with a short
public comment period at the end. The
open session will be videocast and can
be accessed from the NIH Videocasting
and Podcasting website (https://
videocast.nih.gov).
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
General Medical Sciences Council.
Date: September 17, 2020.
Open: 9:30 a.m. to 12:00 p.m.
Agenda: To review and evaluate for the
discussion of program policies and issues;
opening remarks; report of the Director,
NIGMS; and other business of the Council.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892 (Virtual Meeting).
Closed: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate to review
and evaluate grant applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Erica L. Brown, Ph.D.,
Director, Division of Extramural Activities,
National Institute of General Medical
Sciences, National Institutes of Health,
Natcher Building, Room 2AN24F, Bethesda,
MD 20892, (301) 594–4499, erica.brown@
nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
E:\FR\FM\07AUN1.SGM
07AUN1
]]>Agencies
[Federal Register Volume 85, Number 153 (Friday, August 7, 2020)]
[Notices]
[Pages 47971-47972]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-17233]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Notice of Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of meetings of the National Diabetes
and Digestive and Kidney Diseases Advisory Council.
The meetings will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meetings will be closed to the public in accordance with the
provisions set forth in section 552b(c)(6), Title 5 U.S.C., as amended.
The grant applications and the discussions could disclose confidential
trade secrets or commercial property such as patentable material, and
personal information concerning individuals associated with the grant
applications, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: National Diabetes and Digestive and Kidney
Diseases Advisory Council.
Date: September 9, 2020.
Open: 10:30 a.m. to 1:30 p.m.
Agenda: To Present the Director's Report and other Scientific
Presentations.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892, (Virtual Meeting).
Closed: 4:15 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Karl F. Malik, Ph.D., Director, Division of
Extramural Activities, National Institutes of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy Boulevard, Room 7329, MSC 5452,
Bethesda, MD 20892, (301) 594-4757, [email protected].
Name of Committee: National Diabetes and Digestive and Kidney
Diseases Advisory Council; Digestive Diseases and Nutrition.
Date: September 9, 2020.
Open: 2:00 p.m. to 3:00 p.m.
Agenda: To review the Division's scientific and planning
activities.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting).
Closed: 3:15 p.m. to 4:15 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Karl F. Malik, Ph.D., Director, Division of
Extramural Activities, National Institutes of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy Boulevard, Room 7329, MSC 5452,
Bethesda, MD 20892, (301) 594-4757, [email protected].
Name of Committee: National Diabetes and Digestive and Kidney
Diseases Advisory Council; Diabetes, Endocrinology, and Metabolic
Diseases Subcommittee.
Date: September 9, 2020.
Open: 2:00 p.m. to 3:00 p.m.
Agenda: To review the Division's scientific and planning
activities.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting).
Closed: 3:15 p.m. to 4:15 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Karl F. Malik, Ph.D., Director, Division of
Extramural Activities, National Institutes of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy Boulevard, Room 7329, MSC 5452,
Bethesda, MD 20892, (301) 594-4757, [email protected].
Name of Committee: National Diabetes and Digestive and Kidney
Diseases Advisory Council; Kidney, Urologic, and Hematologic
Diseases.
Date: September 9, 2020.
Open: 2:00 p.m. to 3:00 p.m.
Agenda: To review the Division's scientific and planning
activities.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting).
[[Page 47972]]
Closed: 3:15 p.m. to 4:15 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Karl F. Malik, Ph.D., Director, Division of
Extramural Activities, National Institutes of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy Boulevard, Room 7329, MSC 5452,
Bethesda, MD 20892, (301) 594-4757, [email protected].
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
Information is also available on the Institute's/Center's home
page: www.niddk.nih.gov/fund/divisions/DEA/Council/coundesc.html,
where an agenda and any additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes of Health, HHS)
Dated: August 3, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-17233 Filed 8-6-20; 8:45 am]
BILLING CODE 4140-01-P
